US11597788B2 - Light curable composition - Google Patents

Light curable composition Download PDF

Info

Publication number
US11597788B2
US11597788B2 US17/225,864 US202117225864A US11597788B2 US 11597788 B2 US11597788 B2 US 11597788B2 US 202117225864 A US202117225864 A US 202117225864A US 11597788 B2 US11597788 B2 US 11597788B2
Authority
US
United States
Prior art keywords
curable composition
light curable
acrylate
meth
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US17/225,864
Other versions
US20210221930A1 (en
Inventor
Heqiang Zhang
Daoqiang Lu
Chongjian Song
Zuohe Wang
Benchi Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel China Co Ltd
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of US20210221930A1 publication Critical patent/US20210221930A1/en
Assigned to HENKEL AG & CO. KGAA reassignment HENKEL AG & CO. KGAA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Henkel (China) Co. Ltd.
Assigned to Henkel (China) Co. Ltd. reassignment Henkel (China) Co. Ltd. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LU, Benchi, LU, DAOQIANG, SONG, Chongjian, WANG, Zuohe, ZHANG, Heqiang
Application granted granted Critical
Publication of US11597788B2 publication Critical patent/US11597788B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/58—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing oxygen in addition to the carbonamido oxygen, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/56—Acrylamide; Methacrylamide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00—Materials specially adapted for additive manufacturing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B33—ADDITIVE MANUFACTURING TECHNOLOGY
    • B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00—Products made by additive manufacturing
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00—Processes of polymerisation
    • C08F2/46—Polymerisation initiated by wave energy or particle radiation
    • C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/12—Esters of monohydric alcohols or phenols
    • C08F220/16—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms
    • C08F220/18—Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
    • C08F220/1811—C10or C11-(Meth)acrylate, e.g. isodecyl (meth)acrylate, isobornyl (meth)acrylate or 2-naphthyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
    • C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
    • C08F220/282—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
    • C08F222/10—Esters
    • C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
    • C08F222/106—Esters of polycondensation macromers
    • C08F222/1065—Esters of polycondensation macromers of alcohol terminated (poly)urethanes, e.g. urethane(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0041—Optical brightening agents, organic pigments

Definitions

  • This invention relates to a light curable composition, comprising at least one (meth)acrylate monomer, at least one acrylamide compound, at least one (meth)acrylate oligomer, and at least one photoinitiator.
  • the light curable composition of the present invention exhibits excellent elongation property after curing and is suitable to be applied for 3D printing.
  • Three-dimensional (3D) printing processes such as Stereolithography (SLA) and Digital Light Processing (DLP), are based on the layer-wise polymerization of Ultraviolet (UV) sensitive resins.
  • UV sensitive resins widely used for the 3D printing processes.
  • Traditional (meth)acrylic based resins are rigid and have poor elongation property after curing.
  • the products of the traditional (meth)acrylic based resins are fragile, and the application of the products are therefore limited.
  • the present invention relates to a light curable composition, comprising:
  • the light curable composition of the invention exhibits excellent elongation property after curing and is suitable to be applied for 3D printing.
  • the present invention also relates to a cured product of the light curable composition.
  • the cured product of the present invention may be in a form of a 3D article formed from the light curable composition printed by a 3D printer.
  • the present invention also relates to an article bonded by light curable composition.
  • (meth)acrylate refers to both or any one of “acrylate” and “methacrylate”.
  • (meth)acrylic refers to both or any one of “acrylic” and “methacrylic”.
  • the term “monomer” refers to a polymer building block which has a defined molecular structure and which can be reacted to form a part of a polymer.
  • oligomer refers to a molecule that comprises at least two repeat units.
  • hydrocarbon group refers to an organic compound consisting of carbon and hydrogen.
  • Example of hydrocarbon group includes but limited to an alkyl group, such as methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, tertiary butyl, isobutyl and the groups alike; an o alkenyl group, such as vinyl, allyl, butenyl, pentenyl, hexenyl and the groups alike; an aralkyl group, such as benzyl, phenethyl, 2-(2,4,6-trimethylphenyl)propyl and the groups alike; or an aryl group, such as phenyl, tolyl, xyxyl and the groups alike.
  • alkyl group such as methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, tertiary butyl, isobutyl and
  • optionally substituted in the term of “optionally substituted hydrocarbon group” means that one or more hydrogens on the hydrocarbon group may be replaced with a corresponding number of substituents preferably selected from halogen, nitro, azido, amino, carbonyl, ester, cyano, sulfide, sulfate, sulfoxide, sulfone, sulfone groups, and the likes.
  • glass transition temperature refers to a temperature at which a polymer transitions between a highly elastic state and a glassy state. Glass transition temperature may be measured, for example, by differential scanning calorimetry (DSC).
  • DSC differential scanning calorimetry
  • the light curable composition of the present invention comprises at least one (meth)acrylate monomer.
  • the (meth)acrylate monomer refers to any common (meth)acrylate monomer capable of polymerization, and having at least one group represented by the following general formula:
  • R is a hydrogen or a methyl group.
  • Illustrative (meth)acrylate monomers include isobornyl acrylate (IBOA), isobornyl methacrylate (IBOMA), tetrahydrofurfuryl acrylate (THFA), (5-ethyl-1,3-dioxan-5-YI)methyl acrylate, cyclohexyl acrylate, cyclohexyl methacrylate, t-butyl acrylate, t-butyl methacrylate, t-butylcyclohexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, phenyl acrylate, phenyl methacrylate, benzyl acrylate, benzyl methacrylate, phenethyl acrylate, phenethyl methacrylate, dicyclopentanyl acrylate, 3,3,5-trimethylcyclohexyl acrylate, 3,3,5-trimethyl
  • the (meth)acrylate monomer has a glass transition temperature from ⁇ 60 to 120° C., preferably from ⁇ 20 to 120° C., more preferably from 25 to 120° C., and even more preferably from 80 to 100° C. it is surprisingly found that when incorporating (meth)acrylate monomer with proper glass transition temperature, the elongation property of the cured product of the light curable composition can be improved.
  • Examples of commercially available (meth)acrylate monomers are, for example, SR531, SR508 and SR285 from Sartomer.
  • the amount of the (meth)acrylate monomer is preferably from 10 to 90%, and more preferably from 40 to 60% by weight based on the total weight of the light curable composition.
  • the light curable composition of the present invention comprises at least one acrylamide compound.
  • the acrylamide compound refers to a compound having at least one group represented by CH 2 ⁇ CR 4 —CO—N in each molecule, wherein R 4 is a hydrogen or a methyl group.
  • Illustrative acrylamide compounds include 4-acryloylmorpholine (ACMO), N,N-dimethylacrylamide (DMAA), N,N-Diethyl-2-propenamide (DEAA), and N-hydroxyethylacrylamide (HEAA).
  • the acrylamide compound can be used alone or in combination.
  • the light curable composition preferably comprises at least one acrylamide compound having the amide nitrogen as a member of a cyclic group.
  • the cyclic group may be aromatic heterocyclic groups having 4 to 20 atoms in the cyclic group; and saturated and unsaturated aliphatic heterocyclic groups having 4 to 20 atoms in the cyclic group.
  • the cyclic group may contain additional hetero atoms such as N, O, S, P, and Si other than the amide nitrogen atom.
  • the cyclic group may be optionally substituted with by groups selected from alkyl groups of 1 to 6 carbon atoms, hydroxyl, acyloxy, alkoxy of 1 to 6 carbon atoms, cyano, halo, phenyl, and benzo groups.
  • the light curable composition comprises at least one acrylamide compound having the amide nitrogen as a member of a saturated and unsaturated aliphatic heterocyclic group having 4 to 20 atoms in the cyclic group.
  • the light curable composition comprises at least one acrylamide compound having a structure represented by the general formula (1). It is surprisingly found that when incorporating acrylamide compound having a structure represented by the general formula (1), the elongation property of the cured product of the light curable composition can be further improved.
  • R 1 is a hydrogen or a methyl group
  • R 2 and R 3 are each independently an optionally substituted divalent hydrocarbon group.
  • R 2 and R 3 are each independently a C 1 to C 10 optionally substituted divalent hydrocarbon group.
  • the divalent hydrocarbon group include but not limited to a methylene group, ethylene group, and trimethylene group.
  • Examples of commercially available acrylamide compound are ACMOTM, DMAATM and DEAATM from KJ Chemicals corporation.
  • the amount of the acrylamide compound is preferably from 5% to 80%, and more preferably from 10 to 70% by weight based on the total weight of the light curable composition.
  • the light curable composition of the present invention comprises at least one (meth)acrylate oligomer.
  • the (meth)acrylate oligomer refers to an oligomer having at least one acryloyl group or at least one methacrylol group per molecule.
  • the (meth)acrylate oligomer has two acryloyl groups or two methacrylol groups per molecule.
  • Illustrative (meth)acrylate oligomer includes a polyurethane (meth)acrylate oligomer, a polyisoprene (meth)acrylate oligomer, a polybutadiene (meth)acrylate oligomer, a polyester (meth)acrylate oligomer and a polyether (meth)acrylate oligomer.
  • the (meth)acrylate oligomer can be used alone or in combination.
  • polyurethane (meth)acrylate oligomer is used in the light curable composition of the present invention.
  • the (meth)acrylate oligomer has a glass transition temperature from ⁇ 80 to 60° C., preferably from ⁇ 60 to 20° C., more preferably from ⁇ 60 to 0° C., and even more preferably from ⁇ 60 to ⁇ 10° C. It is surprisingly found that when incorporating (meth)acrylate oligomer having a low glass transition temperature, the elongation property of the cured product of the light curable composition can be further improved.
  • Examples of commercially available (meth)acrylate oligomers are, for example, BR-3641AJ, BR-3741AJ, BR-3641AA, BR-345, BRC-443, BRC-443D, BRC-843, BRC-843S, BRC-843D, BR7432 GB, BR-641D, BR-641S, BR-744BT, and BR-744SD from Dymax Oligomers & Coatings; CN8881NS, CN8882NS, CN8883NS, CN8884NS, CN8888NS, and CN9014NS from Sartomer; and EBECRYL-230, EBECRYL-231, EBECRYL-242, EBECRYL-244, EBECRYL-246, EBECRYL-4491, EBECRYL-4483, T EBECRYL-8841, EBECRYL-8804, and EBECRYL-6603 from AlInex Group Companies.
  • the amount of the (meth)acrylate oligomer is preferably from 10% to 90%, and more preferably from 20% to 60% by weight based on the total weight of the light curable composition.
  • the light curable composition of the present invention comprises at least one photoinitiator.
  • the photoinitiator refers to any common photoinitiator and is preferably to include at least one free radical photoinitiator, for example selected from benzophenone, acetophenone, chlorinated acetophenone, dialkoxyacetophenones, dialkylhydroxyacetophenones, dialkylhydroxyacetophenone esters, benzoin acetate, benzoin, benzoin alkyl ethers, dimethoxybenzion, dibenzylketone, benzoylcyclohexanol and other aromatic ketones, acyloxime esters, acylphosphophine oxides, acylphosphosphonates, ketosulfides, dibenzoyldisulphides, diphenyldithiocarbonate, and dipheyl(2,4,6-trimethylbenzoyl) phosphine oxide.
  • the photoinitiator can be used alone or in any combination.
  • Examples of commercially available photoinitiators include but not limited to Irgacure 184, Irgacure 500, Irgacure 907, Irgacure 369, Irgacure 379, Irgacure 127, Irgacure 1700, Irgacure 651, Irgacure 819, Irgacure 1000, Irgacure 1300, Irgacure 1870, Darocur 1173, Darocur 2959, Darocur 4265 and Darocur TPO, from Ciba Specialty Chemicals; Lucerin TPO, from BASF AG; Esacure KT046, Esacure KIP150, EsacureKT37 and Esacure EDB, from LAMBERTI; H-Nu 470 and H-Nu 470X, from SPECTRA GROUP Ltd.; and Genopol TX-1, from Rahn AG.
  • the amount of the photoinitiator of the invention is from 0.1% to 8%, preferably from 1% to 5%, and more preferably from 3% to 5% by weight based on the total weight of the light curable composition.
  • the light curable composition may optionally include at least one fluorescent brightener.
  • the fluorescent brightener includes but not limited to benzoxazole derivatives, bis-benzoxazoles; bis-benzoxazolyl-stilbenes; bis-benzoxazolyl-thiophenes, thiophenediyl benzoxazoles, 2,5-thiophenediylbis-(5-tert-butyl-1,3-benzoxazoles).
  • the fluorescent brightener can be used alone or in combination.
  • fluorescent brighteners examples include but not limited to Tinopal OB and Uvitex OB, from BASF.
  • the amount of the fluorescent brightener of the invention is from 0% to 2%, preferably from 0.05 to 1%, and more preferably from 0.05% to 0.5% by weight based on the total weight of the light curable composition.
  • the light curable composition comprises:
  • the light curable composition of the present invention may be prepared by mixing all the components together by any common method and apparatus known in the art.
  • the light curable composition of the present invention may be cured by actinic ray that has sufficient energy to initiate a polymerization or cross-linking reaction.
  • the actinic ray includes but is not limited to ⁇ -rays, ⁇ -rays, ultraviolet radiation (UV), visible light, and electron beams.
  • UV radiation and electron beams are used for the curing of light curable composition.
  • UV radiation is chosen as the source of energy for the curing of light curable composition.
  • the light curable composition can be cured by UV LED at a wavelength of 405 nm and with an energy of 10-100 mw/cm 2 for 1 to 20 seconds.
  • Representative examples of the UV light source include LED UV cure equipment (model 97070, from Loctite Henkel), and Fusion UV equipment (LH6BPS, from Fusion UV System Inc.).
  • the light curable composition of the present invention may be printed to form a 3D article by the following steps:
  • the light curable composition of the present invention may be printed using a 3D printer, such as Ember from Autodesk; Form 1+ from Formlabs; PR 10 from Henkel; and Lite 100 from Union tech.
  • a 3D printer such as Ember from Autodesk; Form 1+ from Formlabs; PR 10 from Henkel; and Lite 100 from Union tech.
  • the elongation property of the 3D article cured from the light curable composition of the present invention may be assessed according to ASTM638-14.
  • the 3D article cured from the light curable composition of the present invention preferably has an elongation at break greater than or equal to 100%, more preferably greater than or equal to 120%, and even more preferably greater than or equal to 140%.
  • the light curable composition was printed to form a 3D article using an Ember printer from Autodesk, by the following steps:
  • the elongation property of the 3D article formed by the light curable composition was measured according to ASTM D638-14 using Instron Universal test machine at a test speed of 100 mm/min.
  • a light curable composition was prepared, according to Table 1, by mixing the components selected from:
  • the glass transition temperature of the (meth)acrylate monomer and (meth)acrylate oligomer also played a key role for the elongation property of 3D article formed from the light curable composition.
  • Example 2, 5, and 6 when incorporating a (meth)acrylate monomer with high glass transition temperature in the light curable composition, the 3D article had better elongation at break.
  • Example 2, 7, and 8 when incorporating a (meth)acrylate oligomer with low glass transition temperature in the light curable composition, the 3D article had better elongation at break.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)

Abstract

This invention relates to a light curable composition, comprising at least one acrylate monomer, at least one acrylamide compound, at least one acrylate oligomer, and at least one photoinitiator. The light curable composition of the present invention exhibits excellent elongation property after curing and is suitable to be applied for 3D printing.

Description

TECHNICAL FIELD
This invention relates to a light curable composition, comprising at least one (meth)acrylate monomer, at least one acrylamide compound, at least one (meth)acrylate oligomer, and at least one photoinitiator. The light curable composition of the present invention exhibits excellent elongation property after curing and is suitable to be applied for 3D printing.
BACKGROUND OF THE INVENTION
Three-dimensional (3D) printing processes, such as Stereolithography (SLA) and Digital Light Processing (DLP), are based on the layer-wise polymerization of Ultraviolet (UV) sensitive resins. One of the UV sensitive resins widely used for the 3D printing processes is (meth)acrylic based resin. Traditional (meth)acrylic based resins, however, are rigid and have poor elongation property after curing. The products of the traditional (meth)acrylic based resins are fragile, and the application of the products are therefore limited.
Therefore, there is a need for developing a light curable composition having good elongation property after curing, and suitable for 3D printing.
SUMMARY OF THE INVENTION
The present invention relates to a light curable composition, comprising:
    • (a) at least one (meth)acrylate monomer;
    • (b) at least one acrylamide compound;
    • (c) at least one (meth)acrylate oligomer; and
    • (d) at least one photoinitiator.
The light curable composition of the invention exhibits excellent elongation property after curing and is suitable to be applied for 3D printing.
The present invention also relates to a cured product of the light curable composition. The cured product of the present invention may be in a form of a 3D article formed from the light curable composition printed by a 3D printer.
The present invention also relates to an article bonded by light curable composition.
DETAILED DESCRIPTION OF THE INVENTION
In the following passages the present invention is described in more detail. Each aspect so described may be combined with any other aspect or aspects unless clearly indicated to the contrary. In particular, any feature indicated as being preferred or advantageous may be combined with any other feature or features indicated as being preferred or advantageous.
In the context of the present invention, the terms used are to be construed in accordance with the following definitions, unless a context dictates otherwise.
As used herein, the singular forms “a”, “an” and “the” include both singular and plural referents unless the context clearly dictates otherwise.
The terms “comprising”, “comprises” and “comprised of” as used herein are synonymous with “including”, “includes” or “containing”, “contains”, and are inclusive or open-ended and do not exclude additional, non-recited members, elements or process steps.
The recitation of numerical end points includes all numbers and fractions subsumed within the respective ranges, as well as the recited end points.
All references cited in the present specification are hereby incorporated by reference in their entirety.
Unless otherwise defined, all terms used in the disclosing the invention, including technical and scientific terms, have the meaning as commonly understood by one of the ordinary skill in the art to which this invention belongs to. By means of further guidance, term definitions are included to better appreciate the teaching of the present invention.
In the context of this disclosure, a number of terms shall be utilized.
The term “(meth)acrylate” refers to both or any one of “acrylate” and “methacrylate”.
The term “(meth)acrylic” refers to both or any one of “acrylic” and “methacrylic”.
The term “monomer” refers to a polymer building block which has a defined molecular structure and which can be reacted to form a part of a polymer.
The term “oligomer” refers to a molecule that comprises at least two repeat units.
The term “hydrocarbon group” refers to an organic compound consisting of carbon and hydrogen. Example of hydrocarbon group includes but limited to an alkyl group, such as methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, tertiary butyl, isobutyl and the groups alike; an o alkenyl group, such as vinyl, allyl, butenyl, pentenyl, hexenyl and the groups alike; an aralkyl group, such as benzyl, phenethyl, 2-(2,4,6-trimethylphenyl)propyl and the groups alike; or an aryl group, such as phenyl, tolyl, xyxyl and the groups alike.
The term “optionally substituted” in the term of “optionally substituted hydrocarbon group” means that one or more hydrogens on the hydrocarbon group may be replaced with a corresponding number of substituents preferably selected from halogen, nitro, azido, amino, carbonyl, ester, cyano, sulfide, sulfate, sulfoxide, sulfone, sulfone groups, and the likes.
The term “glass transition temperature” refers to a temperature at which a polymer transitions between a highly elastic state and a glassy state. Glass transition temperature may be measured, for example, by differential scanning calorimetry (DSC).
(Meth)Acrylate Monomer
The light curable composition of the present invention comprises at least one (meth)acrylate monomer. The (meth)acrylate monomer refers to any common (meth)acrylate monomer capable of polymerization, and having at least one group represented by the following general formula:
Figure US11597788-20230307-C00001
In the formula above, R is a hydrogen or a methyl group.
Illustrative (meth)acrylate monomers include isobornyl acrylate (IBOA), isobornyl methacrylate (IBOMA), tetrahydrofurfuryl acrylate (THFA), (5-ethyl-1,3-dioxan-5-YI)methyl acrylate, cyclohexyl acrylate, cyclohexyl methacrylate, t-butyl acrylate, t-butyl methacrylate, t-butylcyclohexyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, phenyl acrylate, phenyl methacrylate, benzyl acrylate, benzyl methacrylate, phenethyl acrylate, phenethyl methacrylate, dicyclopentanyl acrylate, 3,3,5-trimethylcyclohexyl acrylate, 3,3,5-trimethylcyclohexyl methacrylate, dicyclopentenyl acrylate, 1,6-hexanediol diacrylate, 2-ethylhexyl acrylate, n-octyl acrylate, n-nonyl acrylate, n-decyl acrylate, isooctyl acrylate, n-lauryl acrylate, n-tridecyl acrylate, n-cetyl acrylate, n-stearyl acrylate, isomyristyl acrylate, and isostearyl acrylate (ISTA). The (meth)acrylate monomer can be used alone or in any combination.
In some embodiments of the present invention, the (meth)acrylate monomer has a glass transition temperature from −60 to 120° C., preferably from −20 to 120° C., more preferably from 25 to 120° C., and even more preferably from 80 to 100° C. it is surprisingly found that when incorporating (meth)acrylate monomer with proper glass transition temperature, the elongation property of the cured product of the light curable composition can be improved.
Examples of commercially available (meth)acrylate monomers are, for example, SR531, SR508 and SR285 from Sartomer.
In some embodiments of the present invention, the amount of the (meth)acrylate monomer is preferably from 10 to 90%, and more preferably from 40 to 60% by weight based on the total weight of the light curable composition.
Acrylamide Compound
The light curable composition of the present invention comprises at least one acrylamide compound. The acrylamide compound refers to a compound having at least one group represented by CH2═CR4—CO—N in each molecule, wherein R4 is a hydrogen or a methyl group. Illustrative acrylamide compounds include 4-acryloylmorpholine (ACMO), N,N-dimethylacrylamide (DMAA), N,N-Diethyl-2-propenamide (DEAA), and N-hydroxyethylacrylamide (HEAA). The acrylamide compound can be used alone or in combination.
In some embodiments of the present invention, the light curable composition preferably comprises at least one acrylamide compound having the amide nitrogen as a member of a cyclic group. The cyclic group may be aromatic heterocyclic groups having 4 to 20 atoms in the cyclic group; and saturated and unsaturated aliphatic heterocyclic groups having 4 to 20 atoms in the cyclic group. The cyclic group may contain additional hetero atoms such as N, O, S, P, and Si other than the amide nitrogen atom. The cyclic group may be optionally substituted with by groups selected from alkyl groups of 1 to 6 carbon atoms, hydroxyl, acyloxy, alkoxy of 1 to 6 carbon atoms, cyano, halo, phenyl, and benzo groups. More preferably, the light curable composition comprises at least one acrylamide compound having the amide nitrogen as a member of a saturated and unsaturated aliphatic heterocyclic group having 4 to 20 atoms in the cyclic group. Even more preferably, the light curable composition comprises at least one acrylamide compound having a structure represented by the general formula (1). It is surprisingly found that when incorporating acrylamide compound having a structure represented by the general formula (1), the elongation property of the cured product of the light curable composition can be further improved.
Figure US11597788-20230307-C00002
In the general formula (1), R1 is a hydrogen or a methyl group; R2 and R3 are each independently an optionally substituted divalent hydrocarbon group. Preferably, R2 and R3 are each independently a C1 to C10 optionally substituted divalent hydrocarbon group. Examples of the divalent hydrocarbon group include but not limited to a methylene group, ethylene group, and trimethylene group.
Examples of commercially available acrylamide compound, for example, are ACMO™, DMAA™ and DEAA™ from KJ Chemicals corporation.
In some embodiments of the present invention, the amount of the acrylamide compound is preferably from 5% to 80%, and more preferably from 10 to 70% by weight based on the total weight of the light curable composition.
(Meth)Acrylate Oligomer
The light curable composition of the present invention comprises at least one (meth)acrylate oligomer. The (meth)acrylate oligomer refers to an oligomer having at least one acryloyl group or at least one methacrylol group per molecule. Preferably, the (meth)acrylate oligomer has two acryloyl groups or two methacrylol groups per molecule. Illustrative (meth)acrylate oligomer includes a polyurethane (meth)acrylate oligomer, a polyisoprene (meth)acrylate oligomer, a polybutadiene (meth)acrylate oligomer, a polyester (meth)acrylate oligomer and a polyether (meth)acrylate oligomer. The (meth)acrylate oligomer can be used alone or in combination. Preferably, polyurethane (meth)acrylate oligomer is used in the light curable composition of the present invention.
In some embodiments of the present invention, the (meth)acrylate oligomer has a glass transition temperature from −80 to 60° C., preferably from −60 to 20° C., more preferably from −60 to 0° C., and even more preferably from −60 to −10° C. It is surprisingly found that when incorporating (meth)acrylate oligomer having a low glass transition temperature, the elongation property of the cured product of the light curable composition can be further improved.
Examples of commercially available (meth)acrylate oligomers are, for example, BR-3641AJ, BR-3741AJ, BR-3641AA, BR-345, BRC-443, BRC-443D, BRC-843, BRC-843S, BRC-843D, BR7432 GB, BR-641D, BR-641S, BR-744BT, and BR-744SD from Dymax Oligomers & Coatings; CN8881NS, CN8882NS, CN8883NS, CN8884NS, CN8888NS, and CN9014NS from Sartomer; and EBECRYL-230, EBECRYL-231, EBECRYL-242, EBECRYL-244, EBECRYL-246, EBECRYL-4491, EBECRYL-4483, T EBECRYL-8841, EBECRYL-8804, and EBECRYL-6603 from AlInex Group Companies.
In some embodiments of the present invention, the amount of the (meth)acrylate oligomer is preferably from 10% to 90%, and more preferably from 20% to 60% by weight based on the total weight of the light curable composition.
Photoinitiator
The light curable composition of the present invention comprises at least one photoinitiator. The photoinitiator refers to any common photoinitiator and is preferably to include at least one free radical photoinitiator, for example selected from benzophenone, acetophenone, chlorinated acetophenone, dialkoxyacetophenones, dialkylhydroxyacetophenones, dialkylhydroxyacetophenone esters, benzoin acetate, benzoin, benzoin alkyl ethers, dimethoxybenzion, dibenzylketone, benzoylcyclohexanol and other aromatic ketones, acyloxime esters, acylphosphophine oxides, acylphosphosphonates, ketosulfides, dibenzoyldisulphides, diphenyldithiocarbonate, and dipheyl(2,4,6-trimethylbenzoyl) phosphine oxide. The photoinitiator can be used alone or in any combination.
Examples of commercially available photoinitiators include but not limited to Irgacure 184, Irgacure 500, Irgacure 907, Irgacure 369, Irgacure 379, Irgacure 127, Irgacure 1700, Irgacure 651, Irgacure 819, Irgacure 1000, Irgacure 1300, Irgacure 1870, Darocur 1173, Darocur 2959, Darocur 4265 and Darocur TPO, from Ciba Specialty Chemicals; Lucerin TPO, from BASF AG; Esacure KT046, Esacure KIP150, EsacureKT37 and Esacure EDB, from LAMBERTI; H-Nu 470 and H-Nu 470X, from SPECTRA GROUP Ltd.; and Genopol TX-1, from Rahn AG.
In some embodiments of the present invention, the amount of the photoinitiator of the invention is from 0.1% to 8%, preferably from 1% to 5%, and more preferably from 3% to 5% by weight based on the total weight of the light curable composition.
Optional Additives
Fluorescent Brightener
The light curable composition may optionally include at least one fluorescent brightener. The fluorescent brightener includes but not limited to benzoxazole derivatives, bis-benzoxazoles; bis-benzoxazolyl-stilbenes; bis-benzoxazolyl-thiophenes, thiophenediyl benzoxazoles, 2,5-thiophenediylbis-(5-tert-butyl-1,3-benzoxazoles). The fluorescent brightener can be used alone or in combination.
Examples of commercially available fluorescent brighteners include but not limited to Tinopal OB and Uvitex OB, from BASF.
In some embodiments of the present invention, the amount of the fluorescent brightener of the invention is from 0% to 2%, preferably from 0.05 to 1%, and more preferably from 0.05% to 0.5% by weight based on the total weight of the light curable composition.
In a preferred embodiment, the light curable composition comprises:
a) from 10 to 90% by weight of at least one (meth)acrylate monomer;
b) from 5 to 80% by weight of at least one acrylamide compound;
c) from 10 to 90% by weight of at least one (meth)acrylate oligomer;
d) from 0.1 to 8% by weight of at least one photoinitiator; and
e) from 0 to 2% by weight of at least one fluorescent brightener;
the weight percentages of all components add up to 100% by weight.
The light curable composition of the present invention may be prepared by mixing all the components together by any common method and apparatus known in the art.
The light curable composition of the present invention may be cured by actinic ray that has sufficient energy to initiate a polymerization or cross-linking reaction. The actinic ray includes but is not limited to α-rays, γ-rays, ultraviolet radiation (UV), visible light, and electron beams. Preferably, UV radiation and electron beams are used for the curing of light curable composition. More preferably, UV radiation is chosen as the source of energy for the curing of light curable composition. For example, the light curable composition can be cured by UV LED at a wavelength of 405 nm and with an energy of 10-100 mw/cm2 for 1 to 20 seconds. Representative examples of the UV light source include LED UV cure equipment (model 97070, from Loctite Henkel), and Fusion UV equipment (LH6BPS, from Fusion UV System Inc.).
The light curable composition of the present invention may be printed to form a 3D article by the following steps:
  • a) a digital model of a 3D article to be printed is provided;
  • b) the digital model of the 3D article is sliced into a number of horizontal planes, and each of the horizontal plane is converted into a two-dimensional image;
  • c) a layer of the light curable composition is deposited on a surface of the building platform;
  • d) one two-dimensional image is projected with aid of the actinic ray onto the layer of the light curable composition for curing;
  • e) another layer of the light curable composition is deposited onto the cured layer of the light curable composition in the previous step; and
  • f) steps of d) and e) are repeated to form the 3D article.
The light curable composition of the present invention may be printed using a 3D printer, such as Ember from Autodesk; Form 1+ from Formlabs; PR 10 from Henkel; and Lite 100 from Union tech.
The elongation property of the 3D article cured from the light curable composition of the present invention may be assessed according to ASTM638-14.
The 3D article cured from the light curable composition of the present invention preferably has an elongation at break greater than or equal to 100%, more preferably greater than or equal to 120%, and even more preferably greater than or equal to 140%.
EXAMPLES
The present invention will be further described and illustrated in detail with reference to the following examples. The examples are intended to assist one skilled in the art to better understand and practice the present invention, however, are not intended to restrict the scope of the present invention. All numbers in the examples are based on weight unless otherwise stated.
Test Methods
Elongation at Break
The light curable composition was printed to form a 3D article using an Ember printer from Autodesk, by the following steps:
  • a) a digital model of a 3D article to be printed was provided according to the type V specimen in ASTM638-14;
  • b) the digital model of the 3D article was sliced into 64 horizontal planes with a height of 0.05 mm for each horizontal plane, and each of the horizontal plane was converted into a two-dimensional image by Autodesk Print Studio software;
  • c) a first layer of the light curable composition was deposited on a surface of the building platform and was left stand for 5 seconds before being exposed to UV radiation;
  • d) a first two-dimensional image was projected with aid of the UV radiation at a wavelength of 405 nm and with an energy of 20 mw/cm2 onto the first layer of the light curable composition, and the first layer of the light curable composition was exposed under the UV radiation for 8 seconds;
  • e) a second layer of the light curable composition was deposited onto the cured first layer and was left stand for 5 seconds before being exposed to UV radiation;
  • f) a second two-dimensional image was projected with aid of the UV radiation at a wavelength of 405 nm and with an energy of 20 mw/cm2 onto the second layer of the light curable composition, and the second layer of the light curable composition was exposed under the UV radiation for 4 seconds;
  • g) a third layer of the light curable composition was deposited onto the cured second layer and was left stand for 1.5 seconds before being exposed to UV radiation;
  • h) a third two-dimensional image was projected with aid of the UV radiation at a wavelength of 405 nm and with an energy of 20 mw/cm2 onto the third layer of the light curable composition, and the third layer of the light curable composition was exposed under the UV radiation for 2.2 seconds;
  • i) steps g) and h) were repeated for the rest of layers to form the 3D article.
The elongation property of the 3D article formed by the light curable composition was measured according to ASTM D638-14 using Instron Universal test machine at a test speed of 100 mm/min.
The percent elongation at break was recorded.
Example 1-9
A light curable composition was prepared, according to Table 1, by mixing the components selected from:
  • ACMO (Acryloyl morpholine, available from KJ Chemicals Corporation);
  • DMAA (N,N-Dimethyl acrylamide, available from KJ Chemicals Corporation);
  • DEAA (N,N-Diethyl acrylamide, available from KJ Chemicals Corporation);
  • TPO (2,4,6-Trimethylbenzoyl diphenyl phosphine oxide, Chivacure TPO, available from Chitec Chemical);
  • Tinopal OB CO (2, 5-thiophenediylbis (5-tert-butyl-1, 3-benzoxazole), available from BASF);
  • Ebecryl 230 (Aliphatic Urethane Diacrylate, available from AlInex Group Companies, Tg=−55° C.);
  • BRC 843S (Hydrophobic Urethane Acrylates, available from Dymax Oligomers & Coatings, Tg=−9° C.);
  • BRC 443D (Hydrophobic Urethane Acrylates, available from Dymax Oligomers & Coatings, Tg=41° C.);
  • SR 531 (5-Ethyl-1,3-Dioxan-5-YI)Methyl Acrylate, available from Sartomer, Tg=32° C.);
  • ISTA ((Isostearyl acrylate, NK ESTER S-1800ALC available from Shin-Nakamura Chemical Co., Ltd., Tg=−18° C.);
  • SR 285 (Tetrahydrofurfuryl acrylate, available from Sartomer, Tg=−15° C.); and
  • SR 506 (Isobornyl acrylate, available from Sartomer, Tg=88° C.).
TABLE 1
Light curable composition
Weight %
Components Ex. 1 Ex. 2 Ex. 3 Ex. 4 Ex. 5 Ex. 6 Ex. 7 Ex. 8 Ex. 9
ACMO 19.4 19.4 19.4 19.4 19.4 19.4
DMAA 19.4
DEAA 19.4
TPO 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4
Tinopal OBCO 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2
Ebecryl 230 40 40 40 40 40 40 40
BRC 843S 30
BRC 443D 30
SR 531 20 40 40 40 50 50 39.4
ISTA 20 20
SR 285 40
SR 506 40
In Table 2, the elongation property of the 3D article formed from the light curable composition is reported. By incorporating acrylamide compound in the light curable composition, the 3D article in Examples from 1 to 8 showed much better elongation at break compared with Example 9. It was further found that when an acrylamide compound having the amide nitrogen as a member of a cyclic group was introduced to the light curable composition, the 3D article exhibited even better elongation at break.
The glass transition temperature of the (meth)acrylate monomer and (meth)acrylate oligomer also played a key role for the elongation property of 3D article formed from the light curable composition. By comparing Example 2, 5, and 6, when incorporating a (meth)acrylate monomer with high glass transition temperature in the light curable composition, the 3D article had better elongation at break. On the contrary, by comparing Example 2, 7, and 8, when incorporating a (meth)acrylate oligomer with low glass transition temperature in the light curable composition, the 3D article had better elongation at break.
TABLE 2
Elongation Property
Ex. 1 Ex. 2 Ex. 3 Ex. 4 Ex. 5 Ex. 6 Ex. 7 Ex.8 Ex.9
Elongation 145 170 134.45 119.55 137.36 310.13 129.42 108.5 78
at break (%)

Claims (6)

What is claimed is:
1. A light curable composition comprising:
(a) from 40 to 60% by weight of at least one (meth)acrylate monomer having a glass transition temperature from −60 to 120° C.;
(b) from 10 to 70% by weight of at least one acrylamide compound;
(c) from 20 to 60% by weight of at least one (meth)acrylate oligomer having a glass transition temperature from −80 to 60° C.; and
(d) from 3 to 5% by weight of at least one photoinitiator; and
(e) from 0.05 to 0.5% by weight of at least one fluorescent brightener selected from the group consisting of benzoxazole derivatives, bis-benzoxazoles; bis-benzoxazolyl-stilbenes; bis-benzoxazolyl-thiophenes, thiophenediyl benzoxazoles, 2,5-thiophenediylbis-(5-tert-butyl-1,3-benzoxazoles);
the weight percentages of all components add up to 100% by weight.
2. The light curable composition according to claim 1, wherein the acrylamide compound comprises an amide nitrogen as a member of a cyclic group.
3. The light curable composition according to claim 2, the cyclic group is a saturated or an unsaturated aliphatic heterocyclic groups having 4 to 20 atoms in the cyclic group.
4. The light curable composition according to claim 1, wherein the acrylamide compound has a structure represented by the general formula (1):
Figure US11597788-20230307-C00003
wherein R1 is a hydrogen or a methyl group; and
R2 and R3 are each independently a C1 to C10 optionally substituted divalent hydrocarbon group.
5. A cured product of the light curable composition according to claim 1.
6. An article bonded by a light curable composition comprising a cured product of the light curable composition according to claim 1.
US17/225,864 2018-10-08 2021-04-08 Light curable composition Active US11597788B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2018/109268 WO2020073149A1 (en) 2018-10-08 2018-10-08 Light curable composition

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2018/109268 Continuation WO2020073149A1 (en) 2018-10-08 2018-10-08 Light curable composition

Publications (2)

Publication Number Publication Date
US20210221930A1 US20210221930A1 (en) 2021-07-22
US11597788B2 true US11597788B2 (en) 2023-03-07

Family

ID=70163736

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/225,864 Active US11597788B2 (en) 2018-10-08 2021-04-08 Light curable composition

Country Status (4)

Country Link
US (1) US11597788B2 (en)
EP (1) EP3864058A4 (en)
CN (1) CN112823171B (en)
WO (1) WO2020073149A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113056496B (en) * 2018-11-19 2023-09-08 应用材料公司 Low viscosity UV curable formulation for 3D printing
CN114181354B (en) * 2021-12-20 2022-07-12 杭州之江有机硅化工有限公司 UV (ultraviolet) photocuring composition with low moisture vapor transmission rate and preparation method thereof
JP7187725B1 (en) 2022-06-01 2022-12-12 第一工業製薬株式会社 Curable composition and electric member

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002572A1 (en) 1990-07-30 1992-02-20 Dsm N.V. Associative reactive blend-containing compositions
JP2014077069A (en) 2012-10-11 2014-05-01 Aica Kogyo Co Ltd Photocurable resin composition
CN105246929A (en) 2014-01-13 2016-01-13 顶科股份有限公司 Photo-curable resin compositions and method of using the same in three-dimensional printing for manufacturing artificial teeth and denture base
KR20160028137A (en) * 2014-09-03 2016-03-11 삼화페인트공업주식회사 Uv curable type transparent color coating composition for pcm
CN106459316A (en) 2014-06-11 2017-02-22 株式会社东进世美肯 Photocurable resin composition
CN106866873A (en) 2017-03-21 2017-06-20 广东丽格科技股份有限公司 A kind of light-cured resin for 3D printer and preparation method thereof
CN107107461A (en) 2015-01-26 2017-08-29 科巨希化学股份公司 Three-dimensional modeling support member actinic energy ray curable resion composition
CN107151482A (en) 2016-03-02 2017-09-12 株式会社理光 Active energy ray-curable composition, curing materials, composition storage container, two dimension or three-dimensional image forming apparatus and method
EP3222683A1 (en) 2016-03-23 2017-09-27 Xerox Corporation Curable gellant ink composition
EP3330306A1 (en) 2015-07-29 2018-06-06 Maxell Holdings, Ltd. Resin composition for model materials, resin composition for support materials, optically shaped article and method for producing optically shaped article
CN108348446A (en) 2015-11-09 2018-07-31 三键有限公司 Nail or artificial nails' Photocurable composition and use its painting method
JP2019001865A (en) 2017-06-13 2019-01-10 セイコーエプソン株式会社 Radiation curable composition and radiation curable composition set
US10357435B2 (en) 2012-12-18 2019-07-23 Dentca, Inc. Photo-curable resin compositions and method of using the same in three-dimensional printing for manufacturing artificial teeth and denture base

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992002572A1 (en) 1990-07-30 1992-02-20 Dsm N.V. Associative reactive blend-containing compositions
JP2014077069A (en) 2012-10-11 2014-05-01 Aica Kogyo Co Ltd Photocurable resin composition
US10357435B2 (en) 2012-12-18 2019-07-23 Dentca, Inc. Photo-curable resin compositions and method of using the same in three-dimensional printing for manufacturing artificial teeth and denture base
CN105246929A (en) 2014-01-13 2016-01-13 顶科股份有限公司 Photo-curable resin compositions and method of using the same in three-dimensional printing for manufacturing artificial teeth and denture base
CN106459316A (en) 2014-06-11 2017-02-22 株式会社东进世美肯 Photocurable resin composition
KR20160028137A (en) * 2014-09-03 2016-03-11 삼화페인트공업주식회사 Uv curable type transparent color coating composition for pcm
US10711149B2 (en) 2015-01-26 2020-07-14 Kj Chemicals Corporation Active energy ray-curable resin composition for three-dimensional model supporting material
CN107107461A (en) 2015-01-26 2017-08-29 科巨希化学股份公司 Three-dimensional modeling support member actinic energy ray curable resion composition
EP3330306A1 (en) 2015-07-29 2018-06-06 Maxell Holdings, Ltd. Resin composition for model materials, resin composition for support materials, optically shaped article and method for producing optically shaped article
US10500144B2 (en) 2015-11-09 2019-12-10 Three Bond Co., Ltd. Photocurable composition to be used on fingernails or artificial nails, and method for coating by using same
CN108348446A (en) 2015-11-09 2018-07-31 三键有限公司 Nail or artificial nails' Photocurable composition and use its painting method
US10239972B2 (en) 2016-03-02 2019-03-26 Ricoh Company, Ltd. Active-energy-ray-curable composition, cured material, composition stored container, two-dimensional or three-dimensional image forming apparatus, and two-dimensional or three-dimensional image forming method
CN107151482A (en) 2016-03-02 2017-09-12 株式会社理光 Active energy ray-curable composition, curing materials, composition storage container, two dimension or three-dimensional image forming apparatus and method
EP3222683A1 (en) 2016-03-23 2017-09-27 Xerox Corporation Curable gellant ink composition
CN106866873A (en) 2017-03-21 2017-06-20 广东丽格科技股份有限公司 A kind of light-cured resin for 3D printer and preparation method thereof
JP2019001865A (en) 2017-06-13 2019-01-10 セイコーエプソン株式会社 Radiation curable composition and radiation curable composition set

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
International Search Report in connection with International Application No. PCT/CN2018/109268 dated Jun. 28, 2019.

Also Published As

Publication number Publication date
WO2020073149A1 (en) 2020-04-16
EP3864058A1 (en) 2021-08-18
CN112823171B (en) 2023-06-30
CN112823171A (en) 2021-05-18
EP3864058A4 (en) 2022-07-20
US20210221930A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
US11597788B2 (en) Light curable composition
JP6277383B2 (en) (Meth) acrylamide urethane oligomer and active energy ray-curable resin composition containing the same
JP7018871B2 (en) One-component curable soft feel coating
EP3320047B1 (en) Curable compositions comprising mono-functional acrylates
JP6232599B2 (en) Urethane-modified (meth) acrylamide compound and active energy ray-curable resin composition containing the same
JP2021146562A (en) Photocurable composition for support material for 3d printer and support material for 3d printer
JP2010155889A (en) Photocurable liquid resin composition and method for producing support by inkjet stereolithography
US11713366B2 (en) Resin composition for model material and method for manufacturing optically shaped article
JP2003048929A (en) Curable resin composition
JP2015165018A (en) Photocurable composition, photocured product obtained therefrom, and pressure-sensitive adhesive
JP6179150B2 (en) Active energy ray-curable composition and cured product
JP6418053B2 (en) Manufacturing method of resin sheet
JP3606260B2 (en) Active energy ray-curable coating composition
JP4504007B2 (en) Elastic sealant composition for building
KR102605107B1 (en) Solvent-free type organic-inorganic hybrid coating compositon and coating film comprising same
JP6575508B2 (en) Photocurable composition
KR101887253B1 (en) Pollution proof acrylic polymer for additive
JP2018197320A (en) Curable composition
US20230105707A1 (en) Radiation-Curable Ink Jet Composition
JP2023078814A (en) Radioactive ray-curable inkjet ink composition, and inkjet recording method
JP2021181542A (en) Photocurable ink composition for inkjet printing
JP2018062584A (en) Curable composition
US20180244818A1 (en) Antifouling acrylic resin for additive
JP2012007041A (en) Polyoxyalkylene-based polymer and curable composition

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID

STPP Information on status: patent application and granting procedure in general

Free format text: WITHDRAW FROM ISSUE AWAITING ACTION

AS Assignment

Owner name: HENKEL AG & CO. KGAA, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:HENKEL (CHINA) CO. LTD.;REEL/FRAME:061329/0064

Effective date: 20180726

Owner name: HENKEL (CHINA) CO. LTD., CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, HEQIANG;SONG, CHONGJIAN;LU, DAOQIANG;AND OTHERS;REEL/FRAME:061329/0013

Effective date: 20180726

STPP Information on status: patent application and granting procedure in general

Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STCF Information on status: patent grant

Free format text: PATENTED CASE